66
Participants
Start Date
October 15, 2021
Primary Completion Date
June 17, 2024
Study Completion Date
July 17, 2024
Omadacycline Oral Tablet
omadacycline 300 mg orally, once daily (150 mg tablets x 2)
Placebo
placebo tablets resembling omadacycline orally, once daily (x 2 tablets)
Einstein/Montefiore Medical Center, The Bronx
Northwell Health, New Hyde Park
Georgetown University Hospital, Washington D.C.
Johns Hopkins University, Baltimore
University of North Carolina at Chapel Hill, Chapel Hill
Medical University of South Carolina (MUSC), Charleston
Emory University School of Medicine, Atlanta
Infectious Disease Consultants of the Treasure Coast, Vero Beach
University of Miami, Miami
University of South Florida, Tampa
St. Francis Medical Institute, Clearwater
University of Wisconsin Hospitals and Clinics, Madison
Louisiana State University Medical Center Health Sciences Center-New Orleans Section of Pulmonary/Critical Care & Allergy/Immunology, New Orleans
The University of Texas Health Science Center at Tyler, Tyler
Stanford University, Stanford
Oregon Health & Science University, Portland
Dartmouth-Hitchcock Medical Center, Lebanon
Lead Sponsor
Paratek Pharmaceuticals Inc
INDUSTRY